Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Timothy P. Lynch currently holds 6,500,000 shares of NABI BIOPHARMACEUTICALS (NABI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Timothy P. Lynch has been a net buyer of NABI stock. They have purchased $243.5K and sold $20.0K worth of shares.
Timothy P. Lynch's most recent insider trade was on Aug 19, 2026, when they purchased 1,150,000 shares at $0.21 per share.
Timothy P. Lynch serves as Executive at NABI BIOPHARMACEUTICALS (NABI). They have executed 8 insider transactions totaling $263.5K over their tenure at the company.
Timothy P. Lynch holds the position of Executive at NABI BIOPHARMACEUTICALS, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Timothy P. Lynch has shown a buying trading pattern, with $243.5K in total purchases and $20.0K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Timothy P. Lynch was on Feb 16, 2010, when they sold $247.7K worth of BFRM shares. This transaction involved 45,454 shares at $5.45 per share.
Timothy P. Lynch currently owns 6,500,000 shares of NABI BIOPHARMACEUTICALS (NABI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Timothy P. Lynch's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Timothy P. Lynch has 8 Form 4 filings on record as an insider at NABI BIOPHARMACEUTICALS.
Set alerts for Timothy P. Lynch and 40,000+ other insiders.